Rongzhi Biotechnology
PrivateLast Round
Strategic
Aug 28, 2019
Est. Valuation
$144.9M
Total Funding Raised
$23.29M
Company Overview
Rongzhi Biotechnology operates in Healthcare & Life Sciences and is based in Qingdao. Its latest recorded funding round was a Strategic round in August 2019.
Rongzhi Biotechnology is a life science company that specializes in the research, development, and production of mass spectrometry and microfluidic analytical instruments for microbial and gene sequencing analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rongzhi Biotechnology Comparables
Compare Rongzhi Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zybio Inc. | 86% | |
| Maccura Biotechnology Co Ltd | 78% | |
| Autobio Diagnostics Co Ltd | 77% |
For institutional investors. Book with your work email.
Rongzhi Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 28, 2019 | ||||
| Series C | Mar 25, 2019 | ||||
| Series B Extension | Dec 1, 2017 | ||||
| Series B | Feb 27, 2017 | ||||
| Series A | Jun 30, 2016 | ||||
Angel | Nov 30, 2014 |
For institutional investors. Book with your work email.
Rongzhi Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Strategic |
| Hosencare Brothers | Series B Extension |
| Shenzhen Sangel Venture Capital | Angel |
| Hosen Capital | Series B Extension, Series C |
| HMC Ventures | Series A |
| Beijing Zhengxin Investment Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2019
$14.5M raised with Cathay Capital participating.
- Mar 25, 2019
Raised $6M with Hosen Capital as lead investor.
For institutional investors. Book with your work email.
Rongzhi Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rongzhi Biotechnology's valuation, stock price, and market status.
Is Rongzhi Biotechnology a public or private company?
Rongzhi Biotechnology is a private company.
What is the current stock price of Rongzhi Biotechnology?
Rongzhi Biotechnology is a private company, so its shares have no public market price. Caplight tracks Rongzhi Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rongzhi Biotechnology worth (valuation)?
Rongzhi Biotechnology's valuation is estimated at $144.9M based on funding round data.
Can I buy Rongzhi Biotechnology stock?
Rongzhi Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rongzhi Biotechnology's last funding round?
Rongzhi Biotechnology's most recent funding round was Strategic on August 28, 2019.
Who are the main investors in Rongzhi Biotechnology?
Key investors in Rongzhi Biotechnology include Cathay Capital, Hosencare Brothers, Shenzhen Sangel Venture Capital, Hosen Capital, HMC Ventures.
Will Rongzhi Biotechnology IPO soon?
No public IPO plans have been announced for Rongzhi Biotechnology.
How can I track Rongzhi Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Rongzhi Biotechnology's shares on secondary markets.